298 related articles for article (PubMed ID: 18606765)
1. Role of aquaglyceroporin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of Leishmania donovani.
Maharjan M; Singh S; Chatterjee M; Madhubala R
Am J Trop Med Hyg; 2008 Jul; 79(1):69-75. PubMed ID: 18606765
[TBL] [Abstract][Full Text] [Related]
2. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
[TBL] [Abstract][Full Text] [Related]
3. Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania.
Marquis N; Gourbal B; Rosen BP; Mukhopadhyay R; Ouellette M
Mol Microbiol; 2005 Sep; 57(6):1690-9. PubMed ID: 16135234
[TBL] [Abstract][Full Text] [Related]
4. Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani.
Kothari H; Kumar P; Sundar S; Singh N
Parasitol Int; 2007 Mar; 56(1):77-80. PubMed ID: 17169604
[TBL] [Abstract][Full Text] [Related]
5. Characterization of natural antimony resistance in Leishmania donovani isolates.
Mittal MK; Rai S; Ashutosh ; Ravinder ; Gupta S; Sundar S; Goyal N
Am J Trop Med Hyg; 2007 Apr; 76(4):681-8. PubMed ID: 17426170
[TBL] [Abstract][Full Text] [Related]
6. Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani.
Potvin JE; Leprohon P; Queffeulou M; Sundar S; Ouellette M
Clin Infect Dis; 2021 May; 72(10):e526-e532. PubMed ID: 32827255
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of proteins in antimony-susceptible and -resistant isolates of Leishmania donovani.
Biyani N; Singh AK; Mandal S; Chawla B; Madhubala R
Mol Biochem Parasitol; 2011 Oct; 179(2):91-9. PubMed ID: 21736901
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.
Mukhopadhyay R; Mukherjee S; Mukherjee B; Naskar K; Mondal D; Decuypere S; Ostyn B; Prajapati VK; Sundar S; Dujardin JC; Roy S
Int J Parasitol; 2011 Nov; 41(13-14):1311-21. PubMed ID: 21920365
[TBL] [Abstract][Full Text] [Related]
9. Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani.
Das S; Shah P; Tandon R; Yadav NK; Sahasrabuddhe AA; Sundar S; Siddiqi MI; Dube A
PLoS Negl Trop Dis; 2015 Aug; 9(8):e0003992. PubMed ID: 26295340
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites.
Singh R; Kumar D; Duncan RC; Nakhasi HL; Salotra P
Int J Antimicrob Agents; 2010 Jul; 36(1):50-7. PubMed ID: 20427152
[TBL] [Abstract][Full Text] [Related]
11. Prokaryotic expression, purification, and polyclonal antibody production against a novel drug resistance gene of Leishmania donovani clinical isolate.
Kothari H; Kumar P; Singh N
Protein Expr Purif; 2006 Jan; 45(1):15-21. PubMed ID: 16289919
[TBL] [Abstract][Full Text] [Related]
12. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.
Samant M; Sahasrabuddhe AA; Singh N; Gupta SK; Sundar S; Dube A
Parasitology; 2007 Aug; 134(Pt 9):1175-84. PubMed ID: 17362540
[TBL] [Abstract][Full Text] [Related]
13. Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance.
Bhandari V; Kumar D; Verma S; Srividya G; Negi NS; Singh R; Salotra P
Biochem Biophys Res Commun; 2013 Nov; 440(4):646-51. PubMed ID: 24103752
[TBL] [Abstract][Full Text] [Related]
14. Novel mechanism of drug resistance in kala azar field isolates.
Singh N; Singh RT; Sundar S
J Infect Dis; 2003 Aug; 188(4):600-7. PubMed ID: 12898450
[TBL] [Abstract][Full Text] [Related]
15. Role of efflux pumps and intracellular thiols in natural antimony resistant isolates of Leishmania donovani.
Rai S; Bhaskar ; Goel SK; Nath Dwivedi U; Sundar S; Goyal N
PLoS One; 2013; 8(9):e74862. PubMed ID: 24069359
[TBL] [Abstract][Full Text] [Related]
16. The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India.
Singh N; Chatterjee M; Sundar S
Parasit Vectors; 2014 Dec; 7():596. PubMed ID: 25515494
[TBL] [Abstract][Full Text] [Related]
17. American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?
Yardley V; Ortuno N; Llanos-Cuentas A; Chappuis F; Doncker SD; Ramirez L; Croft S; Arevalo J; Adaui V; Bermudez H; Decuypere S; Dujardin JC
J Infect Dis; 2006 Oct; 194(8):1168-75. PubMed ID: 16991093
[TBL] [Abstract][Full Text] [Related]
18. Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal.
Decuypere S; Rijal S; Yardley V; De Doncker S; Laurent T; Khanal B; Chappuis F; Dujardin JC
Antimicrob Agents Chemother; 2005 Nov; 49(11):4616-21. PubMed ID: 16251303
[TBL] [Abstract][Full Text] [Related]
19. Telomeric gene deletion and intrachromosomal amplification in antimony-resistant Leishmania.
Mukherjee A; Boisvert S; Monte-Neto RL; Coelho AC; Raymond F; Mukhopadhyay R; Corbeil J; Ouellette M
Mol Microbiol; 2013 Apr; 88(1):189-202. PubMed ID: 23421749
[TBL] [Abstract][Full Text] [Related]
20. Generation of an aquaglyceroporin AQP1 null mutant in Leishmania major.
Plourde M; Ubeda JM; Mandal G; Monte-Neto RL; Mukhopadhyay R; Ouellette M
Mol Biochem Parasitol; 2015 Jun; 201(2):108-11. PubMed ID: 26222914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
